Source: Contract Pharma

Sterling: Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity

A new 2,300-sq.-ft. suite at Deeside, UK site will allow clinical-scale manufacturing using reactors up to 500 liters, doubling the site's capacity

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Kevin Cook's photo - President & CEO of Sterling

President & CEO

Kevin Cook

CEO Approval Rating

88/100

Read more